4BIO Capital
London4biocapital.com
Overview
4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector, investing in and supporting early-stage companies developing treatments in areas of high unmet medical need.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cytospire Therapeutics | May 2026 | Series A | Lead |
| Ray Therapeutics | Apr 2026 | Series B | Co-investor |
| Trogenix | Oct 2025 | Series A | Co-investor |
| Actithera | Jul 2025 | Series A | Lead |
| NV Therapeutics | Mar 2025 | Seed | Lead |
Key People
Dima Kuzmin
Managing Partner
Brian McVeigh
Venture Partner
Tay Salimullah
Venture Partner
Therese Liechtenstein
Partner
Natalie Johnston
Principal
Kieran Mudryy
Partner, General Counsel
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
